Canadian biotech venture capital firm Lumira starts hedge fund to target oversold public companies

Canadian biotech venture capital firm Lumira starts hedge fund to target oversold public companies
Lumira Ventures, one of Canada’s top investors in private health sciences … on established biotherapeutics and medical technology companies, …

See more –> Source